American Association for Cancer Research
Obesity linked to worse outcomes in early breast cancer treatment
Obesity is associated with worse outcomes overall in early-stage breast cancer, researchers reported at the 2011 CTRC-AACR San Antonio Breast Cancer Symposium, held Dec. 6-10, 2011. Obesity was linked to shorter time to recurrence (TT…
MRI may be noninvasive method to measure breast cancer prognosis
Quantitative magnetic resonance imaging measures were associated with prognostic tumor markers, demonstrating the potential of magnetic resonance imaging for prediction of disease prognosis and stratification of patients to appropriate…
Addition of trastuzumab may potentially equalize disease-free survival outcomes among obese and normal-weight patients
SAN ANTONIO — A large, multicenter, randomized study has shown that obese patients with HER2-positive breast cancer have larger tumors, increased lymph node involvement and, when not treated with trastuzumab, poorer long-term outcomes than normal-we…
Addition of bevacizumab to conventional therapy improved progression-free survival in HER2-positive breast cancer
SAN ANTONIO — Data evaluated by an independent review committee revealed that the addition of bevacizumab to trastuzumab and docetaxel significantly improved progression-free survival in HER2-positive breast cancer, despite findings from an investig…
AACR supports NIH stem cell research
PHILADELPHIA — The American Association for Cancer Research (AACR), the world’s oldest and largest cancer research organization, reiterates its support for the responsible conduct of human embryonic stem cell research that, up until this week, wa…
